Sun, J., Sepulveda, J. L., Komissarova, E. V., Hills, C., Seckar, T. D., LeFevre, N. M., Simonyan, H., Young, C., Su, G., Del Portillo, A., Wang, T. C., & Sepulveda, A. R. (2024). CDKN2A-p16 Deletion and Activated KRASG12D Drive Barrett’s-Like Gland Hyperplasia-Metaplasia and Synergize in the Development of Dysplasia Precancer Lesions. Cellular and Molecular Gastroenterology and Hepatology, 17(5), 769–784. https://doi.org/10.1016/j.jcmgh.2024.01.014

Rustgi, S. D., Zylberberg, H. M., Hur, C., & Shah, S. C. (2023). Management of Gastric Intestinal Metaplasia. Clinical Gastroenterology and Hepatology, 21(9), 2178–2182. https://doi.org/10.1016/j.cgh.2023.03.010

Hosseini, M., & Salvatore, M. (2023). Is pulmonary fibrosis a precancerous disease? European Journal of Radiology, 160, 110723. https://doi.org/10.1016/j.ejrad.2023.110723

Gilson Sena, I. F., Fernandes, L. L., Lorandi, L. L., Santana, T. V., Cintra, L., Lima, I. F., Iwai, L. K., Kramer, J. M., Birbrair, A., & Heller, D. (2022). Identification of early biomarkers in saliva in genetically engineered mouse model C(3)1-TAg of breast cancer. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-14514-1

Genere, J. R., Visrodia, K., Zakko, L., Hoefnagel, S. J. M., & Wang, K. K. (2022). Spray cryotherapy versus continued radiofrequency ablation in persistent Barrett’s esophagus. Diseases of the Esophagus, 35(5). https://doi.org/10.1093/dote/doab084